InSight Research and Development is led by a highly specialized teams, working in our in house R&D labs, which are equipped with a wide range of capabilities. Our facilities enable us a complete development of generic drugs, biosimilars and Novel Drugs , from cell line development to regulatory vials filling.
InSight continuously develops, improves and expands its biosimilars R&D activity, including the competitive advantage of:
Cell Line Development: InSight platform automated technologies enable thousands of clones to be screened in an accelerated timeline.
Bioprocess: We have developed a unique approach and process development technique that are strategically combined to high product-yield while meeting the critical quality standards of the reference product.
Analytical Characterization: We have generated unique analytical methodes and technique to enable better monitoring of the chemical and structural similarity between our biosimilar and the reference product.